|
US1354753A
(en)
|
1919-02-11 |
1920-10-05 |
E M Lannes |
Portable building
|
|
US2180006A
(en)
|
1936-09-09 |
1939-11-14 |
Eastman Kodak Co |
Process for the separation and refining of amines
|
|
GB891817A
(en)
|
1959-04-07 |
1962-03-21 |
Upjohn Co |
Improvements in or relating to injectable tetracyclic preparations
|
|
US3843787A
(en)
|
1969-01-15 |
1974-10-22 |
Pierrel Spa |
Water soluble derivative of erythromycin
|
|
US3668282A
(en)
|
1970-05-08 |
1972-06-06 |
Stauffer Chemical Co |
Stabilized mixture employing n-(beta-0,0-dialkyldithiophosphoryl) aryl sulfonamides
|
|
SE458505B
(sv)
|
1979-07-10 |
1989-04-10 |
Lepetit Spa |
Anvaendningen av rifamycin sv och salter daerav foer framstaellning av en beredning foer behandling av reumatoid artrit samt vissa av salterna och deras framstaellning
|
|
US4331803A
(en)
*
|
1980-06-04 |
1982-05-25 |
Taisho Pharmaceutical Co., Ltd. |
Novel erythromycin compounds
|
|
US4474768A
(en)
|
1982-07-19 |
1984-10-02 |
Pfizer Inc. |
N-Methyl 11-aza-10-deoxo-10-dihydro-erytromycin A, intermediates therefor
|
|
JPS59175414A
(ja)
|
1983-03-23 |
1984-10-04 |
Toyo Jozo Co Ltd |
マクロライド抗生物質の安定な経口用製剤および安定化法
|
|
US4742049A
(en)
*
|
1986-06-04 |
1988-05-03 |
Abbott Laboratories |
Semisynthetic erythromycin antibiotics
|
|
KR960000434B1
(ko)
|
1986-12-17 |
1996-01-06 |
다이쇼 세이야꾸 가부시끼가이샤 |
에리스로마이신 a유도체 및 그의 제조 방법
|
|
HU198913B
(en)
|
1987-09-03 |
1989-12-28 |
Pliva Pharm & Chem Works |
Process for producing 10-dihydro-10-deoxo-11-aza-erythronolide a-derivatives and pharmaceutical compositions containing them as active components
|
|
BE1001869A3
(fr)
|
1988-10-12 |
1990-04-03 |
Franz Legros |
Procede d'encapsulation liposomiale d'antibiotiques aminoglucosidiques, en particulier de la gentamycine.
|
|
IL114589A
(en)
*
|
1990-11-21 |
1999-12-22 |
Roussel Uclaf |
Intermediates for the preparation of erythromycin derivatives
|
|
US5985844A
(en)
*
|
1992-03-26 |
1999-11-16 |
Merck & Co., Inc. |
Homoerythromycin A derivatives modified at the 4"-and 8A-positions
|
|
US5527780A
(en)
|
1992-11-05 |
1996-06-18 |
Roussel Uclaf |
Erythromycin derivatives
|
|
FR2697524B1
(fr)
*
|
1992-11-05 |
1994-12-23 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
|
FR2718450B1
(fr)
*
|
1994-04-08 |
1997-01-10 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
|
FR2719587B1
(fr)
|
1994-05-03 |
1996-07-12 |
Roussel Uclaf |
Nouveaux dérivés de l'érythromycine, leur procédé de préparation et leur application comme médicaments.
|
|
US5834428A
(en)
*
|
1995-04-14 |
1998-11-10 |
1149336 Ontario Inc. |
Glucagon-like peptide-2 and its therapeutic use
|
|
WO1997001532A1
(en)
*
|
1995-06-28 |
1997-01-16 |
Tokuyama Corporation |
Ketonitrile derivatives and antibacterial agent and drug containing the same
|
|
FR2739620B1
(fr)
*
|
1995-10-09 |
1997-12-19 |
Roussel Uclaf |
Nouveaux derives de la 5-0-desosaminyl 6-o-methyl erythronolide a, leur procede de preparation et leur application a la preparation de produits biologiquement actifs
|
|
US6274715B1
(en)
|
1995-11-08 |
2001-08-14 |
Abbott Laboratories |
Tricyclic erythromycin derivatives
|
|
US5742049A
(en)
*
|
1995-12-21 |
1998-04-21 |
Bruker-Franzen Analytik Gmbh |
Method of improving mass resolution in time-of-flight mass spectrometry
|
|
FR2742757B1
(fr)
|
1995-12-22 |
1998-01-30 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
|
FR2745290B1
(fr)
*
|
1996-02-28 |
1998-04-03 |
Roussel Uclaf |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
|
US5719272A
(en)
|
1996-04-02 |
1998-02-17 |
Abbott Laboratories |
2'-protected 3'-dimethylamine, 9-etheroxime erythromycin A derivatives
|
|
KR100576988B1
(ko)
*
|
1996-09-04 |
2006-05-10 |
아보트 러보러터리즈 |
항균 활성을 지닌 6-ｏ-치환된 케톨라이드
|
|
KR20000069431A
(ko)
|
1996-12-13 |
2000-11-25 |
피터 지. 스트링거 |
Ｐｓａ의 효소 활성 억제제
|
|
HN1998000086A
(es)
|
1997-06-11 |
1999-03-08 |
Pfizer Prod Inc |
Derivados de 9 - desofo - 9 aza - 9a - homoeritromicina a - c - 4 sustituidos.
|
|
US6407074B1
(en)
*
|
1997-06-11 |
2002-06-18 |
Pfizer Inc |
C-4″-substituted macrolide derivatives
|
|
HN1998000074A
(es)
|
1997-06-11 |
1999-01-08 |
Pfizer Prod Inc |
Derivados de macrolidos c-4 sustituidos
|
|
KR20010013660A
(ko)
|
1997-06-11 |
2001-02-26 |
실버스타인 아써 에이. |
9-옥심 에리트로마이신 유도체
|
|
HN1998000159A
(es)
|
1997-10-29 |
1999-02-09 |
Monsanto Co |
Derivados de 9- amino - 3 ceto eritromicina
|
|
IL135792A0
(en)
|
1997-12-01 |
2001-05-20 |
Abbott Lab |
6-o-alkyl derivatives of erythronolide b
|
|
ID27825A
(id)
*
|
1998-03-26 |
2001-04-26 |
Fujisawa Pharmaceutical Co |
Sediaan lepas lambat
|
|
FR2777282B1
(fr)
*
|
1998-04-08 |
2001-04-20 |
Hoechst Marion Roussel Inc |
Nouveaux derives de la 2-fluoro 3-de((2,6-dideoxy 3-c-methyl 3-0-methyl-alpha-l-ribohexopyranosyl) oxyl) 6-o-methyl 3-oxo erythromycine, leur procede de preparation et leur application a la synthese de principes actifs de medicaments
|
|
US6020521A
(en)
*
|
1998-08-26 |
2000-02-01 |
Abbott Laboratories |
Macrolide LHRH antagonists
|
|
US6387885B1
(en)
|
1998-08-26 |
2002-05-14 |
Abbott Laboratories |
3′,3′-N-bis-desmethyl-3′-N-cycloalkyl erythromycin derivatives as LHRH antagonists
|
|
FR2785612A1
(fr)
*
|
1998-11-10 |
2000-05-12 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
|
FR2786188B1
(fr)
|
1998-11-24 |
2002-10-31 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur applicaion comme medicaments
|
|
KR100317907B1
(ko)
|
1998-11-24 |
2001-12-24 |
김 완 주 |
신규한 중간체, 이를 이용한 마크로라이드계 항생제의제조방법
|
|
DE69933897T2
(de)
|
1998-12-10 |
2007-03-15 |
Pfizer Products Inc., Groton |
Carbamat- und Carbazatketolid-Antibiotika
|
|
ATE256694T1
(de)
|
1999-01-27 |
2004-01-15 |
Pfizer Prod Inc |
Ketolid-antibiotika
|
|
CA2292359C
(en)
|
1999-01-28 |
2004-09-28 |
Pfizer Products Inc. |
Novel azalides and methods of making same
|
|
FR2789392B1
(fr)
|
1999-02-04 |
2001-10-05 |
Hoechst Marion Roussel Inc |
Nouveaux derives de l'erythromycine, leur procede de preparation et leur application comme medicaments
|
|
JP2000351794A
(ja)
|
1999-04-08 |
2000-12-19 |
Hokuriku Seiyaku Co Ltd |
エリスロマイシン誘導体
|
|
AR023264A1
(es)
|
1999-04-08 |
2002-09-04 |
Hokuriku Pharmaceutical |
Derivados de eritromicina
|
|
EP1171447A2
(en)
|
1999-04-16 |
2002-01-16 |
Ortho-McNeil Pharmaceutical, Inc. |
Ketolide antibacterials
|
|
NZ515027A
(en)
*
|
1999-04-16 |
2004-01-30 |
Kosan Biosciences Inc |
Erythromycin derivatives as antibiotics
|
|
US6395300B1
(en)
|
1999-05-27 |
2002-05-28 |
Acusphere, Inc. |
Porous drug matrices and methods of manufacture thereof
|
|
US6420535B1
(en)
|
1999-06-07 |
2002-07-16 |
Abbott Laboratories |
6-O-carbamate ketolide derivatives
|
|
US6437106B1
(en)
|
1999-06-24 |
2002-08-20 |
Abbott Laboratories |
Process for preparing 6-o-substituted erythromycin derivatives
|
|
AU6183700A
(en)
|
1999-08-06 |
2001-03-05 |
Taisho Pharmaceutical Co., Ltd. |
Erythromycin a derivatives
|
|
AU3337900A
(en)
|
1999-08-09 |
2001-03-05 |
Eric Au |
An apparatus for treating wastewater
|
|
US6096922A
(en)
|
1999-11-01 |
2000-08-01 |
Air Products And Chemicals, Inc. |
Process for the synthesis of dialkyl, diaryl, and arylalkyl aminosulfur trifluorides
|
|
KR100336447B1
(ko)
|
1999-11-24 |
2002-05-15 |
민경윤 |
클라리스로마이신의 개선된 제조방법
|
|
JP2001261694A
(ja)
*
|
2000-03-06 |
2001-09-26 |
Pfizer Prod Inc |
ケトライド抗生物質
|
|
ES2242668T3
(es)
*
|
2000-03-15 |
2005-11-16 |
Hanmi Pharm. Co., Ltd. |
Metodo para obtener claritromicina en cristales de forma ii.
|
|
NZ523693A
(en)
|
2000-07-10 |
2004-08-27 |
Chiron Corp |
Macrolide formulations for inhalation and methods of treatment of endobronchial infections
|
|
US20020115621A1
(en)
*
|
2000-08-07 |
2002-08-22 |
Wei-Gu Su |
Macrolide antibiotics
|
|
GB0031312D0
(en)
|
2000-12-21 |
2001-02-07 |
Glaxo Group Ltd |
Macrolides
|
|
EP1320355B1
(en)
*
|
2001-05-18 |
2006-04-05 |
Chiron Corporation |
System for delivering a tobramycin formulation
|
|
AU2002316550A1
(en)
|
2001-07-03 |
2003-01-21 |
Chiron Corporation |
C12 modified erythromycin macrolides and ketolides having antibacterial activity
|
|
US20030176327A1
(en)
*
|
2001-10-25 |
2003-09-18 |
Cassell Gail Houston |
Antibiotics for treating biohazardous bacterial agents
|
|
US20040019012A1
(en)
|
2002-02-22 |
2004-01-29 |
Singh Satish K. |
Ophthalmic antibiotic drug formulations containing a cyclodextrin compound and cetyl pyridinium chloride
|
|
KR101048279B1
(ko)
*
|
2002-05-30 |
2011-07-13 |
더 스크립스 리서치 인스티튜트 |
구리 촉매 작용하에서의 아지드와 아세틸렌과의 리게이션
|
|
CA2491846A1
(en)
*
|
2002-06-17 |
2003-12-24 |
Epigenesis Pharmaceuticals Llc |
Dihydrate dehydroepiandrosterone and methods of treating asthma or chronic obstructive pulmonary disease using compositions thereof
|
|
AU2003255851B2
(en)
|
2002-07-08 |
2009-07-23 |
Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. |
New compounds, compositions and methods for treatment of inflammatory diseases and conditions
|
|
US7091196B2
(en)
*
|
2002-09-26 |
2006-08-15 |
Rib-X Pharmaceuticals, Inc. |
Bifunctional heterocyclic compounds and methods of making and using same
|
|
ITMI20022292A1
(it)
*
|
2002-10-29 |
2004-04-30 |
Zambon Spa |
9a-azalidi ad attivita' antiinfiammatoria.
|
|
EP3738591A3
(en)
|
2003-03-10 |
2021-03-24 |
Merck Sharp & Dohme Corp. |
Novel antibacterial agents
|
|
WO2004096823A2
(en)
|
2003-04-25 |
2004-11-11 |
Chiron Corporation |
Novel ketolide derivatives
|
|
WO2004096822A2
(en)
|
2003-04-25 |
2004-11-11 |
Chiron Corporation |
Pyridyl substituted ketolide antibiotics
|
|
PT1628989E
(pt)
|
2003-05-13 |
2007-03-30 |
Glaxo Group Ltd |
Novos compostos anelares com 14 e 15 membros
|
|
US20050014706A1
(en)
|
2003-07-14 |
2005-01-20 |
Kanakeshwari Falzari |
Method of treating tuberculosis
|
|
US7457520B2
(en)
*
|
2003-07-24 |
2008-11-25 |
Time Warner Cable, Inc. |
Technique for providing a virtual digital video recorder service through a communications network
|
|
GB0402578D0
(en)
|
2004-02-05 |
2004-03-10 |
Cambridge Theranostics Ltd |
Methods of treatment of atherosclerosis
|
|
US20060116336A1
(en)
*
|
2004-03-17 |
2006-06-01 |
American Pharmaceutical Partners, Inc. |
Lyophilized azithromycin formulation
|
|
US7468428B2
(en)
|
2004-03-17 |
2008-12-23 |
App Pharmaceuticals, Llc |
Lyophilized azithromycin formulation
|
|
CA2559281A1
(en)
|
2004-04-28 |
2005-11-10 |
Alembic Limited |
Process for the preparation of telithromycin
|
|
AU2005240849B2
(en)
|
2004-05-06 |
2008-10-23 |
Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. |
Ester linked macrolides useful for the treatment of microbial infections
|
|
WO2006080954A1
(en)
*
|
2004-07-28 |
2006-08-03 |
Ranbaxy Laboratories Limited |
Ketolide derivatives as antibacterial agents
|
|
GB0424958D0
(en)
|
2004-11-11 |
2004-12-15 |
Glaxo Group Ltd |
Novel compounds
|
|
GB0424959D0
(en)
|
2004-11-11 |
2004-12-15 |
Glaxo Group Ltd |
Novel compounds
|
|
JP2008526947A
(ja)
|
2005-01-14 |
2008-07-24 |
グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ |
抗マラリア活性を有する９ａ−カルバモイル−γ−アミノプロピル−および９ａ−チオカルバモイル−γ−アミノプロピル−アザリド
|
|
US20080227730A1
(en)
|
2005-01-14 |
2008-09-18 |
Glaxosmithkline Istrazivacki Centar Zagreb D.O.O. |
9A-Carbamoyl and Thiocarbamoyl Azalides With Antimalarial Activity
|
|
ATE523519T1
(de)
|
2005-01-14 |
2011-09-15 |
Glaxo Group Ltd |
Makrolidverbindungen mit biotin und fotoaffinitätsgruppe zur identifizierung eines makrolid-targets
|
|
CA2601709C
(en)
|
2005-03-22 |
2017-02-14 |
Azevan Pharmaceuticals, Inc. |
Beta-lactamylalkanoic acids
|
|
CA2614412A1
(en)
|
2005-07-07 |
2007-01-18 |
Elan Pharma International, Limited |
Nanoparticulate clarithromycin formulations
|
|
EP1910346B1
(en)
|
2005-07-19 |
2019-02-27 |
Azevan Pharmaceuticals, Inc. |
Beta-lactamyl phenylalanine, cysteine, and serine vasopressin antagonist
|
|
JP5405114B2
(ja)
|
2005-10-31 |
2014-02-05 |
レオ ファーマ アクティーゼルスカブ |
抗生物質である結晶フシジン酸の調製
|
|
GB0522715D0
(en)
|
2005-11-08 |
2005-12-14 |
Helperby Therapeutics Ltd |
New use
|
|
US20070167382A1
(en)
*
|
2005-11-15 |
2007-07-19 |
Nina Finkelstein |
Crystalline and amorphous forms of telithromycin
|
|
US20090005325A1
(en)
*
|
2005-11-23 |
2009-01-01 |
Biswajit Bas |
Ketolide Derivatives as Antibacterial Agents
|
|
US20090075916A1
(en)
*
|
2005-11-23 |
2009-03-19 |
Upadhyay Dilip J |
Use of Macrolide Derivatives for Treating Acne
|
|
DOP2006000268A
(es)
*
|
2005-12-22 |
2007-07-31 |
Pfizer Prod Inc |
Agentes antibacterianos
|
|
CN101045063B
(zh)
|
2006-03-28 |
2011-01-26 |
广州朗圣药业有限公司 |
注射用克拉霉素水溶性制剂
|
|
JP5126685B2
(ja)
|
2006-05-01 |
2013-01-23 |
大正製薬株式会社 |
マクロライド誘導体
|
|
WO2007143507A2
(en)
|
2006-06-05 |
2007-12-13 |
Auspex Pharmaceuticals, Inc. |
Preparation and utility of substituted erythromycin analogs
|
|
DE102006036199B4
(de)
*
|
2006-08-03 |
2016-01-07 |
Deere & Company |
Förderzusammenbau und Presse
|
|
CN101129383B
(zh)
*
|
2006-08-25 |
2014-04-02 |
天津和美生物技术有限公司 |
含氨基糖苷类抗生素的抗生素复方
|
|
WO2009055557A1
(en)
*
|
2007-10-25 |
2009-04-30 |
Cempra Pharmaceuticals, Inc. |
Process for the preparation of macrolide antibacterial agents
|
|
US20090209547A1
(en)
*
|
2008-02-15 |
2009-08-20 |
In Jong Kim |
C-8 halogenated macrolides
|
|
DK2358379T3
(en)
*
|
2008-10-24 |
2016-03-07 |
Cempra Pharmaceuticals Inc |
BIOFORSVAR USING TRIAZOLHOLDIGE macrolides
|
|
US9814657B2
(en)
|
2009-04-27 |
2017-11-14 |
Premier Dental Products Company |
Buffered microencapsulated compositions and methods
|
|
WO2011008193A1
(en)
|
2009-07-13 |
2011-01-20 |
Cempra Pharmaceuticals Inc. |
Fusidic acid dosing regimens for treatment of bacterial infections
|
|
EP2475253B1
(en)
|
2009-09-10 |
2016-10-26 |
Cempra Pharmaceuticals, Inc. |
Methods for treating malaria, tuberculosis and mac diseases
|
|
US20110119604A1
(en)
|
2009-11-19 |
2011-05-19 |
Clevest Solutions Inc. |
System and method for a configurable and extensible allocation and scheduling tool
|
|
CN109091489A
(zh)
|
2010-03-10 |
2018-12-28 |
森普拉制药公司 |
大环内酯类抗生素的肠胃外制剂
|
|
JP5711352B2
(ja)
|
2010-03-22 |
2015-04-30 |
センプラ ファーマシューティカルズ，インコーポレイテッド |
マクロライドの結晶形、およびその使用
|
|
WO2011146829A1
(en)
|
2010-05-20 |
2011-11-24 |
Cempra Pharmaceuticals, Inc. |
Processes for preparing macrolides and ketolides and intermediates therefor
|
|
US8247394B2
(en)
|
2010-06-02 |
2012-08-21 |
Cempra Pharmaceuticals Inc. |
Methods of treating urethritis and related infections using fusidic acid
|
|
US9260473B2
(en)
|
2010-07-19 |
2016-02-16 |
Virginia Commonwealth University |
Bivalent multifunctional ligands targeting Aβ oligomers as treatment for Alzheimer's disease
|
|
WO2012030513A2
(en)
|
2010-08-30 |
2012-03-08 |
Cempra Pharmaceuticals Inc. |
Methods of treating bacterial infections through pulmonary delivery of fusidic acid
|
|
US9815863B2
(en)
|
2010-09-10 |
2017-11-14 |
Cempra Pharmaceuticals, Inc. |
Hydrogen bond forming fluoro ketolides for treating diseases
|
|
WO2012042534A2
(en)
|
2010-09-28 |
2012-04-05 |
Glenmark Generics Limited |
Processes for the preparation of r-sitagliptin and intermediates thereof
|
|
WO2012162439A2
(en)
|
2011-05-23 |
2012-11-29 |
Cem-102 Pharmaceuticals, Inc. |
Compositions comprising fusidic acid and packages therefor
|
|
EP2748165B1
(en)
|
2011-08-27 |
2016-11-02 |
Wockhardt Limited |
1,6-diazabicyclo[3,2,1]octan-7-one derivatives and their use in the treatment of bacterial infections.
|
|
HK1199725A1
(en)
|
2011-08-29 |
2015-07-17 |
无限药品股份有限公司 |
Heterocyclic compounds and uses thereof
|
|
WO2013059610A1
(en)
|
2011-10-20 |
2013-04-25 |
Trius Therapeutics, Inc. |
Therapeutic combination of daptomycin and protein synthesis inhibitor antibiotic, and methods of use
|
|
US10188674B2
(en)
|
2012-03-27 |
2019-01-29 |
Cempra Pharmaceuticals, Inc. |
Parenteral formulations for administering macrolide antibiotics
|
|
EP2968801B1
(en)
|
2013-03-14 |
2018-09-26 |
Cempra Pharmaceuticals, Inc. |
Methods for treating respiratory diseases and formulations therefor
|
|
CN105188712A
(zh)
|
2013-03-15 |
2015-12-23 |
森普拉制药公司 |
用于制备大环内酯抗菌剂的收敛方法
|
|
CA3130061C
(en)
|
2013-04-04 |
2024-05-28 |
President And Fellows Of Harvard College |
Macrolides and methods of their preparation and use
|
|
WO2015123256A1
(en)
|
2014-02-14 |
2015-08-20 |
Cempra Pharmaceuticals, Inc. |
Compositions and methods for treating diabetes and liver diseases
|
|
EP3148966A1
(en)
|
2014-05-27 |
2017-04-05 |
Dipharma Francis S.r.l. |
Azidoalkylamine salts and their use as intermediates
|
|
CA2957034A1
(en)
|
2014-08-05 |
2016-02-11 |
Cempra Pharmaceuticals, Inc. |
Powder oral suspension formulations of antibacterial agents
|
|
CN107405355A
(zh)
|
2015-03-06 |
2017-11-28 |
森普拉制药公司 |
用于制备氟酮内酯的方法
|